GB9526691D0 - Medical use of proteases - Google Patents

Medical use of proteases

Info

Publication number
GB9526691D0
GB9526691D0 GBGB9526691.2A GB9526691A GB9526691D0 GB 9526691 D0 GB9526691 D0 GB 9526691D0 GB 9526691 A GB9526691 A GB 9526691A GB 9526691 D0 GB9526691 D0 GB 9526691D0
Authority
GB
United Kingdom
Prior art keywords
proteases
medical use
medical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
GBGB9526691.2A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cortecs Ltd
Original Assignee
Cortecs Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cortecs Ltd filed Critical Cortecs Ltd
Priority to GBGB9526691.2A priority Critical patent/GB9526691D0/en
Publication of GB9526691D0 publication Critical patent/GB9526691D0/en
Priority to ZA9610433A priority patent/ZA9610433B/en
Priority to PCT/GB1996/003089 priority patent/WO1997024138A2/en
Priority to JP9524091A priority patent/JP2000502697A/en
Priority to AU11818/97A priority patent/AU1181897A/en
Priority to EP96942449A priority patent/EP0876153A2/en
Pending legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46Hydrolases (3)
    • A61K38/48Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482Serine endopeptidases (3.4.21)
    • A61K38/4826Trypsin (3.4.21.4) Chymotrypsin (3.4.21.1)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46Hydrolases (3)
    • A61K38/48Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/4873Cysteine endopeptidases (3.4.22), e.g. stem bromelain, papain, ficin, cathepsin H
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K39/39Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00Antiparasitic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y304/00Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/21Serine endopeptidases (3.4.21)
    • C12Y304/21004Trypsin (3.4.21.4)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y304/00Hydrolases acting on peptide bonds, i.e. peptidases (3.4)
    • C12Y304/22Cysteine endopeptidases (3.4.22)
    • C12Y304/22002Papain (3.4.22.2)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00Medicinal preparations containing antigens or antibodies
    • A61K2039/555Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511Organic adjuvants
    • A61K2039/55516Proteins; Peptides
GBGB9526691.2A 1995-12-29 1995-12-29 Medical use of proteases Pending GB9526691D0 (en)

Priority Applications (6)

Application Number Priority Date Filing Date Title
GBGB9526691.2A GB9526691D0 (en) 1995-12-29 1995-12-29 Medical use of proteases
ZA9610433A ZA9610433B (en) 1995-12-29 1996-12-11 Medical use of proteases.
PCT/GB1996/003089 WO1997024138A2 (en) 1995-12-29 1996-12-13 Medical use of proteases
JP9524091A JP2000502697A (en) 1995-12-29 1996-12-13 Use of proteases in medicine
AU11818/97A AU1181897A (en) 1995-12-29 1996-12-13 Medical use of proteases
EP96942449A EP0876153A2 (en) 1995-12-29 1996-12-13 Medical use of proteases

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB9526691.2A GB9526691D0 (en) 1995-12-29 1995-12-29 Medical use of proteases

Publications (1)

Publication Number Publication Date
GB9526691D0 true GB9526691D0 (en) 1996-02-28

Family

ID=10786186

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB9526691.2A Pending GB9526691D0 (en) 1995-12-29 1995-12-29 Medical use of proteases

Country Status (6)

Country Link
EP (1) EP0876153A2 (en)
JP (1) JP2000502697A (en)
AU (1) AU1181897A (en)
GB (1) GB9526691D0 (en)
WO (1) WO1997024138A2 (en)
ZA (1) ZA9610433B (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020102253A1 (en) 1997-02-25 2002-08-01 Mynott Tracey Lehanne Component of bromelain
JP2001513636A (en) 1997-02-25 2001-09-04 コルテクス(ユーケイ)リミティッド Bromelain ingredients
DE19726254C2 (en) * 1997-06-20 1999-10-21 Mucos Pharma Gmbh & Co Tolerance induction through proteases
DE19726244C2 (en) * 1997-06-20 2000-03-02 Mucos Pharma Gmbh & Co Use of proteolytic enzymes and rutoside to prevent or treat graft rejection
DE19726255C2 (en) * 1997-06-20 2000-03-16 Mucos Pharma Gmbh & Co Influence of cytokines by proteolytic enzymes and rutoside
DE19957318A1 (en) * 1999-11-29 2001-06-21 Mucos Pharma Gmbh & Co Influence of TGF-beta by proteolytic enzymes
DE10018980A1 (en) * 2000-04-17 2001-11-08 Mucos Pharma Gmbh & Co Prophylaxis and therapy of diabetes mellitus I using proteolytic enzymes

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9412711D0 (en) * 1994-06-24 1994-08-17 Cortecs Ltd Medical use of bromelain

Also Published As

Publication number Publication date
AU1181897A (en) 1997-07-28
WO1997024138A2 (en) 1997-07-10
ZA9610433B (en) 1998-06-11
WO1997024138A3 (en) 1997-10-16
JP2000502697A (en) 2000-03-07
EP0876153A2 (en) 1998-11-11

Similar Documents

Publication Publication Date Title
SI1445259T1 (en) Use of crystal forms of 2-methyl-thieno-benzodiazepine
GB9526560D0 (en) Use of 2-Amino-Heterocycles
ZA943047B (en) Human osteoclast-derived cathepsin
IL114331A0 (en) Medical use of bromelain
GB9418762D0 (en) Use of substituted cyclopentane-DI-and-triones
HU9700071D0 (en) Use of muramilpeptides
ZA96725B (en) Use of phenyclyclohexylcarboxamides
SG42309A1 (en) Medical use of enzymes
IL113992A0 (en) Use of copolymer-1
GB9526691D0 (en) Medical use of proteases
HUP9901448A3 (en) Novel medical use
GB9403344D0 (en) Medical application of bromelain
AU5697996A (en) Peptidyl compounds and their therapeutic use
HUP9800272A3 (en) Use of penciclovir for the treatment of human herpes-virus-8
PL319344A1 (en) Gene of human galactokinase
GB9523066D0 (en) Compounds and their therapeutic use
IL117844A0 (en) Use of (s)-adenosyl-l-methionine
IL118225A0 (en) Use of felodipine
GB9313189D0 (en) Medical use of enzymes
GB9308164D0 (en) Medical use of enzymes
GB9523473D0 (en) Diagnosis of toxicoinfectious clostridiosis
GB9502739D0 (en) Diagnosis of toxicoinfections clostridiosis
PL319345A1 (en) Gene of human galactokinase
ZA934714B (en) Medical use of enzymes
ZA963738B (en) Peptidyl compounds and their therapeutic use